Risk for adverse events attributable to statins low when used for primary prevention of cardiovascular disease
In contrast, much higher event rate seen for racial and ethnic minorities randomly assigned to drug therapy in CABANA trial
Intensive BP lowering after intracerebral hemorrhage linked to poorer outcomes in patients with decreased renal function
Despite drop in diabetes-related outpatient visits and testing, no negative association found with glycemic control
Please login or register first to view this content.
